Metropolis Healthcare Q2 Profit Rises 43% As Revenue Grows 16%, Margins Expand

Metropolis Healthcare reported a strong Q2 FY27 performance, with revenue rising 16% year-on-year to ₹497 crore and profit after tax increasing 43% to ₹75 crore. EBITDA grew 24% to ₹135 crore, while EBITDA margin expanded 180 basis points to 27.2%. Patient and test volumes grew 10% and 11%, respectively, with strong growth across the company’s B2C, B2B, preventive wellness and specialty diagnostics businesses. Business Today TV speaks to Surendran Chemmenkotil, Managing Director, Metropolis Healthcare Limited, on the quarterly performance, margin expansion, growth in Tier II and III markets, specialty and preventive diagnostics, network expansion and the growth outlook.